Farms.com Home   Ag Industry News

U.S. could fall to No. 2 in global soybean production

U.S. could fall to No. 2 in global soybean production

Brazil may overtake the U.S., a USDA report says

By Diego Flammini
Staff Writer
Farms.com

The U.S. may not be the world’s leader in soybean production by year’s end.

“Brazil is forecast to overtake the United States as the leading soybean producer in the world during the 2019-20 season,” a Dec. 27 report from the USDA’s Foreign Agricultural Service said. “Production is forecast at 123.5 million metric tons (MMT) based on trend yields.”

The U.S. yield, on the other hand, is forecast to be “less than 100 MMT in 2019-20, a drop of almost 20 percent on the previous season,” the report says.

Even with Brazil’s forecasted production, soybean prices may not be affected.

Prices could fall “but it depends on demand,” said Moe Agostino, chief commodity strategist with Farms.com Risk Management. “But, really, it could just be that Brazil gains export market share as (that country’s production) continues to grow.”

In August 2019, the USDA forecasted global soybean demand for the 2019-20 marketing year at 148.86 MMT, a 1 percent increase from 2018.

America has been the world’s top soybean-producing country since around the time of the Second World War. U.S. farmers doubled their production between 1941 and 1942 from 106 to 188 million bushels to support the war efforts, the Soy Info Center says.

The U.S. has led the world in soybean production every year since 1940. The one exception was 1947, when China produced the most soybeans.

Today, the U.S., Brazil and Argentina account for about 82 percent of global soybean production.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.